JP2733492B2 - イミダゾピリジン誘導体 - Google Patents

イミダゾピリジン誘導体

Info

Publication number
JP2733492B2
JP2733492B2 JP63073036A JP7303688A JP2733492B2 JP 2733492 B2 JP2733492 B2 JP 2733492B2 JP 63073036 A JP63073036 A JP 63073036A JP 7303688 A JP7303688 A JP 7303688A JP 2733492 B2 JP2733492 B2 JP 2733492B2
Authority
JP
Japan
Prior art keywords
group
compound
hydrogen atom
alkyl group
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP63073036A
Other languages
English (en)
Japanese (ja)
Other versions
JPS63258475A (ja
Inventor
パスカル・ジョルジュ
ジョン・アレン
ギュイ・ジョラン
ダニエル・ドゥ・ペレティ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANTERABO SA
Original Assignee
SANTERABO SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8704276A external-priority patent/FR2612927B1/fr
Priority claimed from FR8704277A external-priority patent/FR2612928B1/fr
Application filed by SANTERABO SA filed Critical SANTERABO SA
Publication of JPS63258475A publication Critical patent/JPS63258475A/ja
Application granted granted Critical
Publication of JP2733492B2 publication Critical patent/JP2733492B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP63073036A 1987-03-27 1988-03-25 イミダゾピリジン誘導体 Expired - Fee Related JP2733492B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR874276 1987-03-27
FR8704276A FR2612927B1 (fr) 1987-03-27 1987-03-27 Derives d'imidazopyridines, leur preparation et leur application en therapeutique
FR874277 1987-03-27
FR8704277A FR2612928B1 (fr) 1987-03-27 1987-03-27 Derives hydroxyles d'imidazopyridines, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
JPS63258475A JPS63258475A (ja) 1988-10-25
JP2733492B2 true JP2733492B2 (ja) 1998-03-30

Family

ID=26225872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63073036A Expired - Fee Related JP2733492B2 (ja) 1987-03-27 1988-03-25 イミダゾピリジン誘導体

Country Status (17)

Country Link
US (1) US4847263A (no)
EP (1) EP0289371B1 (no)
JP (1) JP2733492B2 (no)
KR (1) KR880011155A (no)
AR (1) AR243523A1 (no)
AU (1) AU597809B2 (no)
CA (1) CA1324139C (no)
DE (1) DE3865073D1 (no)
DK (1) DK167388A (no)
ES (1) ES2026666T3 (no)
FI (1) FI881434A (no)
GR (1) GR3003145T3 (no)
HU (1) HU198048B (no)
IL (1) IL85840A (no)
NO (1) NO881333L (no)
NZ (1) NZ224032A (no)
PT (1) PT87090B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
US5032595A (en) * 1989-11-24 1991-07-16 Fidia-Georgetown Institute For The Neurosciences Method of stimulating steroidogenesis with alpidem
FR2727864B1 (fr) 1994-12-12 1997-04-04 Synthelabo Utilisation des ligands des sites de liaison peripherique pour les benzodiazepines pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques
AUPP278498A0 (en) 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
WO2001074813A2 (en) * 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS
DE60128211T2 (de) 2000-03-31 2008-01-10 Ortho-Mcneil Pharmaceutical, Inc. Phenyl-substituierte imidazopyridine
EP1292304B1 (en) * 2000-04-24 2005-11-02 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrate
EP1541146B1 (en) 2000-04-24 2006-12-20 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrate solvate
CN100408577C (zh) * 2002-07-15 2008-08-06 台湾神隆股份有限公司 咪唑并(1,2-a)吡啶-3-乙酰胺类的制备方法
CA2509561A1 (en) * 2002-12-18 2004-07-15 Mallinckrodt Inc. Synthesis of heteroaryl acetamides
US20080262025A1 (en) * 2004-07-16 2008-10-23 Yatendra Kumar Processes for the Preparation of Zolpidem and its Hemitartrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1442707A (en) * 1973-07-07 1976-07-14 Yoshitomi Pharmaceutical Substituted phenylalkanoic acids and their derivatives and pharma ceutical compositions thereof
US4221796A (en) * 1979-09-19 1980-09-09 E. R. Squibb & Sons, Inc. Substituted imidazolo-pyridines and method
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2568880B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
ATE62687T1 (de) * 1986-01-22 1991-05-15 Synthelabo Acylaminomethylimidazo(1,2-a>pyrimidinderivate, ihre herstellung und therapeutische verwendung.
FR2599368B1 (fr) * 1986-06-02 1988-08-05 Synthelabo Derives hydroxyles d'imidazopyridines, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
IL85840A (en) 1992-03-29
FI881434A (fi) 1988-09-28
CA1324139C (en) 1993-11-09
JPS63258475A (ja) 1988-10-25
HUT46692A (en) 1988-11-28
DK167388A (da) 1988-09-28
AU597809B2 (en) 1990-06-07
FI881434A0 (fi) 1988-03-25
NO881333L (no) 1988-09-28
NZ224032A (en) 1990-05-28
IL85840A0 (en) 1988-09-30
ES2026666T3 (es) 1992-05-01
PT87090B (pt) 1992-07-31
DK167388D0 (da) 1988-03-25
NO881333D0 (no) 1988-03-25
EP0289371A1 (fr) 1988-11-02
DE3865073D1 (de) 1991-10-31
PT87090A (pt) 1988-04-01
KR880011155A (ko) 1988-10-26
HU198048B (en) 1989-07-28
GR3003145T3 (en) 1993-02-17
EP0289371B1 (fr) 1991-09-25
AR243523A1 (es) 1993-08-31
US4847263A (en) 1989-07-11
AU1373688A (en) 1988-09-29

Similar Documents

Publication Publication Date Title
JP2733492B2 (ja) イミダゾピリジン誘導体
NZ251804A (en) Aromatic quinazoline derivatives and medicaments
CA2104883A1 (fr) Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant
JPH04217983A (ja) ９−（１，３−ジヒドロキシ−２−プロポキシメチル）グアニンの合成中間体及びこれらの化合物の製造方法
WO1993013097A1 (en) Anti-rheumatic naphthyridine derivatives
CN101124229B (zh) 用于治疗炎性和过敏性障碍的新杂环化合物
DE69533043T2 (de) Acrylamid-derivate und verfahren zu deren herstellung
JPH07503022A (ja) ピリドン誘導体，その製造方法およびその医薬としての使用
KR100286786B1 (ko) 2,7-치환된옥타하이드로-피롤로[1,2-에이]피라진유도체
KR910009934B1 (ko) 카르바모일-2-피롤리디논 화합물
FR2483929A1 (fr) Nouvelles adenosines n6-substituees utiles comme medicaments antihypertenseurs, compositions therapeutiques et formes pharmaceutiques les contenant, et leur procede de preparation
JP2818198B2 (ja) Ｎ‐（５，６，７，８‐テトラヒドロピリド［２，３‐ｄ］ピリミジン‐６‐イルアルカノイル）グルタミン酸誘導体
EP0136198B1 (fr) Dérivés de triazolo pyrimidine, leur procédé de préparation et leur application thérapeutique en tant que toni-cardiaques
EP0115714A1 (fr) Composition pharmaceutique à action psychotrope dopanimergique
GB2096143A (en) Imidazo(1,2-a)quinoline derivatives
CA1225645A (en) Substituted 9h-8-oxo-pyrimido[2,1-f]purine-2,4- diones, process for their production and pharmaceutical compositions containing them
JPS59144765A (ja) ２−（１−ピペラジニル）ピリミジン、その製造方法およびそれを含む医薬組成物
JP2875605B2 (ja) ３―エキソメチレンピロロ［２，１―ｂ］チアゾール誘導体
JPH11512734A (ja) Ｐｎｐインヒビターとしてのプリンとグアニンの誘導体
KR920008823B1 (ko) 디아자비시클로알칸 유도체
WO1997012888A1 (en) Purine and guanine derivatives
WO1986000069A1 (fr) NOUVEAUX DERIVES DE L'AMINOMETHYL-6 FURO-(3,4-c)-PYRIDINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS THERAPEUTIQUES LES CONTENANT
KR830002567B1 (ko) 퀴나졸린 유도체의 제조방법
JPH03284691A (ja) 抗ウイルス性ヌクレオシド
JPH0417191B2 (no)

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees